Literature DB >> 22689086

Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease.

Luciano Selistre1, Vandréa de Souza, Bruno Ranchin, Aoumeur Hadj-Aissa, Pierre Cochat, Laurence Dubourg.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) in children is often regarded as a benign condition. However, previous studies pointed out renal-related anomalies which may benefit from early appropriate treatments. This study was conducted to evaluate the prevalence and severity of early renal dysfunction in ADPKD children.
METHODS: An extensive renal evaluation was performed in 52 consecutive ADPKD patients diagnosed either from prenatal screening or post-natal ultrasound (US) examination (54 % males, mean age 10 ± 4 years [1-17]).
RESULTS: Three patients had both systolic (SBP) and diastolic (DBP) blood pressure above the 95th percentile, one patient had a "high normal" DBP, and one child was treated with an angiotensin-converting enzyme inhibitor (ACEI). The mean ± SD glomerular filtration rate (GFR ml/min per 1.73 m(2), inulin clearance) was 115 ± 26 [47-168] but six children (12 %) had a GFR < 90 and 11 (21 %) experienced hyperfiltration (GFR > 135). Microalbuminuria (2 < Ualb/Ucr ≤ 20 mg/mmol) was found in 25 patients and five had macroalbuminuria (>20 mg/mmol).
CONCLUSIONS: Early renal manifestations are frequent in ADPKD children, including hypertension in 6 %, albuminuria in 58 %, and decreased GFR in 12 %. In conclusion, renal function in children with ADPKD should be regularly assessed in order to manage early renal dysfunction and even consider further therapeutic intervention.

Entities:  

Mesh:

Year:  2012        PMID: 22689086     DOI: 10.1007/s00467-012-2192-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Progression of autosomal-dominant polycystic kidney disease in children.

Authors:  G M Fick-Brosnahan; Z V Tran; A M Johnson; J D Strain; P A Gabow
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

2.  Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Kim McFann; Xiang-Dong Yan; Godela M Fick-Brosnahan; Melissa Cadnapaphornchai; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

3.  Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome.

Authors:  Alireza Abdollah Shamshirsaz; Abdollah Shamshirsaz; Mir Reza Bekheirnia; Reza M Bekheirnia; Mohammad Kamgar; Ann M Johnson; K McFann; Melissa Cadnapaphornchai; Niloofar Nobakhthaghighi; N N Haghighi; Robert W Schrier
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

4.  Early renal abnormalities in autosomal dominant polycystic kidney disease.

Authors:  Esther Meijer; Mieneke Rook; Hilde Tent; Gerjan Navis; Eric J van der Jagt; Paul E de Jong; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

5.  Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm.

Authors:  Justine Bacchetta; Jérôme Harambat; Laurence Dubourg; Brigitte Guy; Aurélia Liutkus; Isabelle Canterino; Behrouz Kassaï; Guy Putet; Pierre Cochat
Journal:  Kidney Int       Date:  2009-06-10       Impact factor: 10.612

6.  Prospective change in renal volume and function in children with ADPKD.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-04       Impact factor: 8.237

Review 7.  Vasopressin antagonists in polycystic kidney disease.

Authors:  Vicente E Torres
Journal:  Semin Nephrol       Date:  2008-05       Impact factor: 5.299

8.  New equations to estimate GFR in children with CKD.

Authors:  George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

9.  Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease.

Authors:  Hubert Wong; Laura Vivian; Gabrielle Weiler; Guido Filler
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

Review 10.  Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.

Authors:  Dana Rizk; Arlene Chapman
Journal:  Pediatr Nephrol       Date:  2008-02-08       Impact factor: 3.714

View more
  13 in total

1.  Prevalence of Hypertension in Children with Early-Stage ADPKD.

Authors:  Laura Massella; Djalila Mekahli; Dušan Paripović; Larisa Prikhodina; Nathalie Godefroid; Anna Niemirska; Ayşe Ağbaş; Karolina Kalicka; Augustina Jankauskiene; Malgorzata Mizerska-Wasiak; Alberto Caldas Afonso; Rémi Salomon; Georges Deschênes; Gema Ariceta; Z Birsin Özçakar; Ana Teixeira; Ali Duzova; Jérôme Harambat; Tomáš Seeman; Gabriela Hrčková; Adrian Catalin Lungu; Svetlana Papizh; Amira Peco-Antic; Stéphanie De Rechter; Ugo Giordano; Marietta Kirchner; Teresa Lutz; Franz Schaefer; Olivier Devuyst; Elke Wühl; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-19       Impact factor: 8.237

Review 2.  From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.

Authors:  Djalila Mekahli; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

Review 3.  The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.

Authors:  Bharathi V Reddy; Arlene B Chapman
Journal:  Pediatr Nephrol       Date:  2016-03-31       Impact factor: 3.714

Review 4.  Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Res       Date:  2013-10-31       Impact factor: 3.756

Review 5.  Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Authors:  Stéphanie De Rechter; Luc Breysem; Djalila Mekahli
Journal:  Front Pediatr       Date:  2017-12-20       Impact factor: 3.418

Review 6.  Non-Traditional Risk Factors of Albuminuria in the Pediatric Population: A Scoping Review.

Authors:  Erick Sierra-Diaz; Alfredo de Jesus Celis-de la Rosa; Felipe Lozano-Kasten; Alejandro Bravo-Cuellar; Mariana Garcia-Gutierrez; Hernandez-Flores Georgina
Journal:  Int J Environ Res Public Health       Date:  2017-10-16       Impact factor: 3.390

7.  Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jan Dudley; Paul Winyard; Matko Marlais; Oliver Cuthell; Tess Harris; Jiehan Chong; John Sayer; Daniel P Gale; Lucy Moore; Kay Turner; Sarah Burrows; Richard Sandford
Journal:  BMC Nephrol       Date:  2019-04-30       Impact factor: 2.388

Review 8.  Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.

Authors:  Eric G Benz; Erum A Hartung
Journal:  Pediatr Nephrol       Date:  2021-01-21       Impact factor: 3.651

9.  Prevalence of Albuminuria in Children Living in a Rural Agricultural and Fishing Subsistence Community in Lake Chapala, Mexico.

Authors:  Felipe Lozano-Kasten; Erick Sierra-Diaz; Alfredo de Jesus Celis-de la Rosa; María Margarita Soto Gutiérrez; Alejandro Aarón Peregrina Lucano
Journal:  Int J Environ Res Public Health       Date:  2017-12-14       Impact factor: 3.390

10.  Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.

Authors:  William E Sweeney; Philip Frost; Ellis D Avner
Journal:  World J Nephrol       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.